Useful Serum Pepsinogen Levels for Detecting Ongoing Helicobacter pylori Infection in Asymptomatic Subjects: A Cross-Sectional Study Based on 13C-urea Breath Test Findings

Background /Aims The serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels for the detection of Helicobacter pylori infection. This study aimed to determine the PG assay findings for detecting ongoing infection. Meth...

Full description

Saved in:
Bibliographic Details
Published inDigestive diseases and sciences Vol. 67; no. 12; pp. 5602 - 5609
Main Authors Jeong, Jong Hyeon, Lee, Sun-Young, Kim, Jeong Hwan, Sung, In-Kyung, Park, Hyung Seok
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2022
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0163-2116
1573-2568
1573-2568
DOI10.1007/s10620-022-07471-2

Cover

Abstract Background /Aims The serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels for the detection of Helicobacter pylori infection. This study aimed to determine the PG assay findings for detecting ongoing infection. Methods Asymptomatic subjects who underwent a 13 C-urea breath test ( 13 C-UBT) on the day of gastroscopy and serum assay for cancer screening were included. Subjects with a recent intake of acid suppressants or antibiotics, gastrectomy, or renal failure were excluded. H. pylori infection was defined as a positive 13 C-UBT result. Results Among the 500 included subjects, 167 (33.4%) had current infection. The serum PG II levels of > 12.95 ng/mL (area under the curve [AUC] = 0.930, sensitivity 86.5%, specificity 90.7%) and PG I/II ratios of < 4.35 (AUC = 0.875, sensitivity 86.8%, specificity 79.6%) were related to infection. The PG I/II ratios were inversely correlated with age ( r  = -0.160, p  = 0.039). The cutoff values of PG I/II ratios were lower in older subjects aged ≥ 50 years (< 4.05; AUC = 0.875, sensitivity 80.7%, specificity 88.2%) than in younger subjects aged < 50 years (< 4.35; AUC = 0.873, sensitivity 77.4%, specificity 88.9%). Conclusions Serum PG II levels > 12.95 ng/mL and PG I/II ratios < 4.35 suggest ongoing infection in asymptomatic subjects; therefore, H. pylori confirmation tests ( i.e. , 13 C-UBT) should be considered under these conditions. Stricter criteria are required in older subjects aged ≥ 50 years (PG I/II ratio < 4.05) to detect ongoing infection than younger subjects.
AbstractList The serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels for the detection of Helicobacter pylori infection. This study aimed to determine the PG assay findings for detecting ongoing infection.BACKGROUND /AIMSThe serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels for the detection of Helicobacter pylori infection. This study aimed to determine the PG assay findings for detecting ongoing infection.Asymptomatic subjects who underwent a 13C-urea breath test (13C-UBT) on the day of gastroscopy and serum assay for cancer screening were included. Subjects with a recent intake of acid suppressants or antibiotics, gastrectomy, or renal failure were excluded. H. pylori infection was defined as a positive 13C-UBT result.METHODSAsymptomatic subjects who underwent a 13C-urea breath test (13C-UBT) on the day of gastroscopy and serum assay for cancer screening were included. Subjects with a recent intake of acid suppressants or antibiotics, gastrectomy, or renal failure were excluded. H. pylori infection was defined as a positive 13C-UBT result.Among the 500 included subjects, 167 (33.4%) had current infection. The serum PG II levels of > 12.95 ng/mL (area under the curve [AUC] = 0.930, sensitivity 86.5%, specificity 90.7%) and PG I/II ratios of < 4.35 (AUC = 0.875, sensitivity 86.8%, specificity 79.6%) were related to infection. The PG I/II ratios were inversely correlated with age (r = -0.160, p = 0.039). The cutoff values of PG I/II ratios were lower in older subjects aged ≥ 50 years (< 4.05; AUC = 0.875, sensitivity 80.7%, specificity 88.2%) than in younger subjects aged < 50 years (< 4.35; AUC = 0.873, sensitivity 77.4%, specificity 88.9%).RESULTSAmong the 500 included subjects, 167 (33.4%) had current infection. The serum PG II levels of > 12.95 ng/mL (area under the curve [AUC] = 0.930, sensitivity 86.5%, specificity 90.7%) and PG I/II ratios of < 4.35 (AUC = 0.875, sensitivity 86.8%, specificity 79.6%) were related to infection. The PG I/II ratios were inversely correlated with age (r = -0.160, p = 0.039). The cutoff values of PG I/II ratios were lower in older subjects aged ≥ 50 years (< 4.05; AUC = 0.875, sensitivity 80.7%, specificity 88.2%) than in younger subjects aged < 50 years (< 4.35; AUC = 0.873, sensitivity 77.4%, specificity 88.9%).Serum PG II levels > 12.95 ng/mL and PG I/II ratios < 4.35 suggest ongoing infection in asymptomatic subjects; therefore, H. pylori confirmation tests (i.e., 13C-UBT) should be considered under these conditions. Stricter criteria are required in older subjects aged ≥ 50 years (PG I/II ratio < 4.05) to detect ongoing infection than younger subjects.CONCLUSIONSSerum PG II levels > 12.95 ng/mL and PG I/II ratios < 4.35 suggest ongoing infection in asymptomatic subjects; therefore, H. pylori confirmation tests (i.e., 13C-UBT) should be considered under these conditions. Stricter criteria are required in older subjects aged ≥ 50 years (PG I/II ratio < 4.05) to detect ongoing infection than younger subjects.
Background /AimsThe serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels for the detection of Helicobacter pylori infection. This study aimed to determine the PG assay findings for detecting ongoing infection.MethodsAsymptomatic subjects who underwent a 13C-urea breath test (13C-UBT) on the day of gastroscopy and serum assay for cancer screening were included. Subjects with a recent intake of acid suppressants or antibiotics, gastrectomy, or renal failure were excluded. H. pylori infection was defined as a positive 13C-UBT result.ResultsAmong the 500 included subjects, 167 (33.4%) had current infection. The serum PG II levels of > 12.95 ng/mL (area under the curve [AUC] = 0.930, sensitivity 86.5%, specificity 90.7%) and PG I/II ratios of < 4.35 (AUC = 0.875, sensitivity 86.8%, specificity 79.6%) were related to infection. The PG I/II ratios were inversely correlated with age (r = -0.160, p = 0.039). The cutoff values of PG I/II ratios were lower in older subjects aged ≥ 50 years (< 4.05; AUC = 0.875, sensitivity 80.7%, specificity 88.2%) than in younger subjects aged < 50 years (< 4.35; AUC = 0.873, sensitivity 77.4%, specificity 88.9%).ConclusionsSerum PG II levels > 12.95 ng/mL and PG I/II ratios < 4.35 suggest ongoing infection in asymptomatic subjects; therefore, H. pylori confirmation tests (i.e., 13C-UBT) should be considered under these conditions. Stricter criteria are required in older subjects aged ≥ 50 years (PG I/II ratio < 4.05) to detect ongoing infection than younger subjects.
Background /Aims The serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels for the detection of Helicobacter pylori infection. This study aimed to determine the PG assay findings for detecting ongoing infection. Methods Asymptomatic subjects who underwent a 13 C-urea breath test ( 13 C-UBT) on the day of gastroscopy and serum assay for cancer screening were included. Subjects with a recent intake of acid suppressants or antibiotics, gastrectomy, or renal failure were excluded. H. pylori infection was defined as a positive 13 C-UBT result. Results Among the 500 included subjects, 167 (33.4%) had current infection. The serum PG II levels of > 12.95 ng/mL (area under the curve [AUC] = 0.930, sensitivity 86.5%, specificity 90.7%) and PG I/II ratios of < 4.35 (AUC = 0.875, sensitivity 86.8%, specificity 79.6%) were related to infection. The PG I/II ratios were inversely correlated with age ( r  = -0.160, p  = 0.039). The cutoff values of PG I/II ratios were lower in older subjects aged ≥ 50 years (< 4.05; AUC = 0.875, sensitivity 80.7%, specificity 88.2%) than in younger subjects aged < 50 years (< 4.35; AUC = 0.873, sensitivity 77.4%, specificity 88.9%). Conclusions Serum PG II levels > 12.95 ng/mL and PG I/II ratios < 4.35 suggest ongoing infection in asymptomatic subjects; therefore, H. pylori confirmation tests ( i.e. , 13 C-UBT) should be considered under these conditions. Stricter criteria are required in older subjects aged ≥ 50 years (PG I/II ratio < 4.05) to detect ongoing infection than younger subjects.
Author Lee, Sun-Young
Sung, In-Kyung
Kim, Jeong Hwan
Jeong, Jong Hyeon
Park, Hyung Seok
Author_xml – sequence: 1
  givenname: Jong Hyeon
  orcidid: 0000-0002-1440-6525
  surname: Jeong
  fullname: Jeong, Jong Hyeon
  organization: Department of Internal Medicine, Division of Gastroenterology, Konkuk University School of Medicine
– sequence: 2
  givenname: Sun-Young
  orcidid: 0000-0003-4146-6686
  surname: Lee
  fullname: Lee, Sun-Young
  email: sunyoung@kuh.ac.kr
  organization: Department of Internal Medicine, Division of Gastroenterology, Konkuk University School of Medicine
– sequence: 3
  givenname: Jeong Hwan
  orcidid: 0000-0002-2503-2688
  surname: Kim
  fullname: Kim, Jeong Hwan
  organization: Department of Internal Medicine, Division of Gastroenterology, Konkuk University School of Medicine
– sequence: 4
  givenname: In-Kyung
  orcidid: 0000-0002-3848-5571
  surname: Sung
  fullname: Sung, In-Kyung
  organization: Department of Internal Medicine, Division of Gastroenterology, Konkuk University School of Medicine
– sequence: 5
  givenname: Hyung Seok
  orcidid: 0000-0003-3141-4858
  surname: Park
  fullname: Park, Hyung Seok
  organization: Department of Internal Medicine, Division of Gastroenterology, Konkuk University School of Medicine
BookMark eNp9kc9q3DAQxkVJoZs0L9CToJdenOqPJdm9bbZJE1hIYJOz0crjrRZbciU5sM_Ul6xcFwo55KIRzO-b-WbmHJ057wChT5RcUULU10iJZKQgjBVElYoW7B1aUaF4wYSsztCKUJn_lMoP6DzGIyGkVlSu0O_nCN3U4x2EacCPMEbr_AEc3sIL9BF3PuDvkMAk6w74wR38HO-gt8bvtUkQ8HjqfbD43nUz5R22Dq_jaRiTH3SyBu-m_TGn4je8xpvgYyx2C6lz3zS1J3ytI7Q4SynfFFMAja_zk37iJ4gJ31rX5q7xI3rf6T7C5b94gZ5vb542d8X24cf9Zr0tDKtYKuqylDpvQtbSdEaqqmzBEF2RlgheyqolNdSGCso7o5hq90JoA1rVZbuHrmb8An1Z6o7B_5qyg2aw0UDfawd-ig2TpZJCVLLK6OdX6NFPIQ-WKcVFSTnhc8Fqocw8fYCuMTbpeQMpaNs3lDTzFZvlik323vy9YjNL2SvpGOygw-ltEV9EMcPuAOG_qzdUfwAfNbLQ
CitedBy_id crossref_primary_10_7704_kjhugr_2022_0045
crossref_primary_10_1111_hel_12998
crossref_primary_10_7704_kjhugr_2023_0015
Cites_doi 10.7704/kjhugr.2019.19.2.88
10.1136/gut.50.1.13
10.1097/MD.0000000000007603
10.1155/2014/481607
10.5009/gnl18399
10.2188/jea.JE20170094
10.1111/j.1440-1746.2011.06692.x
10.1111/j.1365-2036.2004.01970.x
10.3748/wjg.v26.i25.3673
10.1136/gutjnl-2020-322368
10.1111/1751-2980.12144
10.1159/000081517
10.1097/MD.0000000000026562
10.7704/kjhugr.2020.0036
10.1007/s005350300060
10.5009/gnl19091
10.1111/jgh.12987
10.1016/j.cgh.2010.12.009
10.1016/j.cgh.2007.11.016
10.1111/hel.12385
10.1111/hel.12480
10.1099/jmm.0.000050
10.1111/hel.12683
10.1007/s00535-005-1677-x
10.1111/j.1440-1746.2011.06893.x
10.1007/s10096-018-3414-4
10.1155/2018/8796165
10.1080/00365521.2019.1686058
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
– notice: 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
DBID AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s10620-022-07471-2
DatabaseName CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
Health & Medical Collection (Alumni Edition)
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-2568
EndPage 5609
ExternalDocumentID 10_1007_s10620_022_07471_2
GrantInformation_xml – fundername: Ministry of Education
  grantid: NRF2016R1D1A1B02008937
  funderid: http://dx.doi.org/10.13039/501100002701
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
-~X
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
354
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AAKAS
AANXM
AANZL
AAQQT
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZCM
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BKNYI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IH2
IHE
IHR
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
J5H
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
KOW
KPH
L7B
LAK
LLZTM
M0R
M1P
M4Y
MA-
MJL
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OHH
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RXW
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJN
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TAE
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
VVN
W23
W48
WH7
WJK
WK8
WOW
X7M
XOL
YLTOR
YOC
Z45
Z7U
Z7V
Z7W
Z7X
Z81
Z82
Z83
Z87
Z88
Z8O
Z8P
Z8Q
Z8R
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
ZY1
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c282t-9446a022696cfc6784dec0a80d053468d09e9c1513fc727db55acea794dbef923
IEDL.DBID U2A
ISSN 0163-2116
1573-2568
IngestDate Tue Oct 14 01:21:16 EDT 2025
Mon Oct 06 18:30:39 EDT 2025
Thu Apr 24 23:01:03 EDT 2025
Wed Oct 01 04:24:52 EDT 2025
Fri Feb 21 02:44:33 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Pepsinogen
Urea breath test
Gastric cancer screening
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c282t-9446a022696cfc6784dec0a80d053468d09e9c1513fc727db55acea794dbef923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4146-6686
0000-0002-2503-2688
0000-0002-3848-5571
0000-0003-3141-4858
0000-0002-1440-6525
PQID 2735413032
PQPubID 41056
PageCount 8
ParticipantIDs proquest_miscellaneous_2647655868
proquest_journals_2735413032
crossref_citationtrail_10_1007_s10620_022_07471_2
crossref_primary_10_1007_s10620_022_07471_2
springer_journals_10_1007_s10620_022_07471_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20221200
2022-12-00
20221201
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: 20221200
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
PublicationTitle Digestive diseases and sciences
PublicationTitleAbbrev Dig Dis Sci
PublicationYear 2022
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Cheng, Tsai, Yang, Yeh, Chang, Kuo, Lu, Sheu (CR24) 2017; 22
Massarrat, Haj-Sheykholeslami, Mohamadkhani, Zendehdel, Aliasgari, Rakhshani, Stolte, Shahidi (CR26) 2014; 2014
Kim, Lee, Lee, Kim, Sung, Park, Shim, Han (CR2) 2018; 23
Baek, Kim, Kwon, Lee, Kim, Lee, Yoon, Shin, Park, Lee (CR7) 2020; 14
Lorente, Doiz, Trinidad Serrano, Castillo, Lanas (CR22) 2002; 50
Iijima, Sekine, Koike, Imatani, Ohara, Shimosegawa (CR25) 2005; 40
Kim (CR13) 2019; 19
Haj-sheykholeslami, Rakhshani, Amirzargar, Rafiee, Shahidi, Nikbin, Khosravi, Massarrat (CR17) 2008; 6
Di Mario, Moussa, Cavallaro, Caruana, Merli, Bertolini, Iori, Cavestro, Dal Bò, Pilotto, Franzé, Leandro (CR19) 2004; 70
Kwak, Chung, Chung, Kang, Yang, Kim (CR5) 2018; 2018
Kiyohira, Yoshihara, Ito, Haruma, Tanaka, Chayama (CR9) 2003; 38
Cho, Jeon, Jin, Park (CR16) 2019; 54
Gatta, Di Mario, Vaira, Rugge, Franzè, Plebani, Cavestro, Lucarini, Lera, Scarpignato (CR27) 2011; 9
Choi, Lee, Kim, Sung, Park, Shim, Jin (CR29) 2014; 15
Ohkusa, Miwa, Nomura, Asaoka, Kurosawa, Sakamoto, Abe, Hojo, Terai, Ogihara, Sato (CR28) 2004; 20
Kim, Lee, Kim, Sung, Park (CR14) 2020; 25
Ito, Yoshihara, Takata, Wada, Matsuo, Boda, Tanaka, Chayama (CR8) 2012; 27
Liou, Malfertheiner, Lee, Sheu, Sugano, Cheng, Yeoh, Hsu, Goh, Mahachai, Gotoda, Chang, Chen, Chiang, Chen, Wu, Leow, Wu, Wu, Hong, Lu, Yamaoka, Megraud, Chan, Sung, Lin, Graham, Wu, El-Omar (CR1) 2020; 69
Cho, Jeon, Kim, Jin, Park (CR6) 2017; 96
Kitamura, Yoshihara, Ito, Boda, Matsuo, Kotachi, Tanaka, Chayama (CR21) 2015; 30
Lee, Moon, Hur, Yun (CR12) 2015; 64
He, Sun, Gong, Xu, Dong, Yuan (CR10) 2011; 26
Yu, Liu, Jiang, Zhou, Guan, Dong, Chu, Kang, Gao (CR23) 2021; 100
Kwon, Lee, Kim, Lee, Kim, Sung, Park, Shim (CR11) 2019; 13
Yuan, Zhao, Zhou, Qi, Guo, Zhang, Khan, Lan, Jia, Zhang, Ding (CR18) 2020; 26
Kikuchi, Kato, Mabe, Kawai, Furuta, Inoue, Ito, Yoshihara, Kodama, Murakami (CR20) 2019; 29
Best, Takwoingi, Siddique, Selladurai, Gandhi, Low, Yaghoobi, Gurusamy (CR4) 2018; 3
Sabbagh, Mohammadnia-Afrouzi, Javanian, Babazadeh, Koppolu, Vasigala, Nouri, Ebrahimpour (CR3) 2019; 38
Lee (CR15) 2021; 21
H Yu (7471_CR23) 2021; 100
HS Choi (7471_CR29) 2014; 15
GH Kim (7471_CR13) 2019; 19
JY Kim (7471_CR14) 2020; 25
S Massarrat (7471_CR26) 2014; 2014
M Ito (7471_CR8) 2012; 27
MS Kwak (7471_CR5) 2018; 2018
K Kiyohira (7471_CR9) 2003; 38
Y Kitamura (7471_CR21) 2015; 30
L Yuan (7471_CR18) 2020; 26
JH Cho (7471_CR6) 2017; 96
LM Best (7471_CR4) 2018; 3
JM Liou (7471_CR1) 2020; 69
A Haj-sheykholeslami (7471_CR17) 2008; 6
L Gatta (7471_CR27) 2011; 9
JH Kim (7471_CR2) 2018; 23
K Iijima (7471_CR25) 2005; 40
SY Lee (7471_CR15) 2021; 21
T Ohkusa (7471_CR28) 2004; 20
SM Baek (7471_CR7) 2020; 14
SY Lee (7471_CR12) 2015; 64
S Lorente (7471_CR22) 2002; 50
F Di Mario (7471_CR19) 2004; 70
CY He (7471_CR10) 2011; 26
P Sabbagh (7471_CR3) 2019; 38
H Kwon (7471_CR11) 2019; 13
S Kikuchi (7471_CR20) 2019; 29
HC Cheng (7471_CR24) 2017; 22
JH Cho (7471_CR16) 2019; 54
References_xml – volume: 19
  start-page: 88
  year: 2019
  end-page: 93
  ident: CR13
  article-title: Endoscopic findings of Kyoto classification of gastritis
  publication-title: Korean J Helicobacter Up Gastrointest Res
  doi: 10.7704/kjhugr.2019.19.2.88
– volume: 50
  start-page: 13
  year: 2002
  end-page: 18
  ident: CR22
  article-title: Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells
  publication-title: Gut
  doi: 10.1136/gut.50.1.13
– volume: 96
  start-page: e7603
  year: 2017
  ident: CR6
  article-title: The serum pepsinogen levels for risk assessment of gastric neoplasms: new proposal from a case-control study in Korea
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000007603
– volume: 2014
  start-page: 481607
  year: 2014
  ident: CR26
  article-title: Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication
  publication-title: Biomed Res Int
  doi: 10.1155/2014/481607
– volume: 13
  start-page: 522
  year: 2019
  end-page: 530
  ident: CR11
  article-title: ABC classification is less useful for older Koreans born before 1960
  publication-title: Gut Liver
  doi: 10.5009/gnl18399
– volume: 29
  start-page: 147
  year: 2019
  end-page: 154
  ident: CR20
  article-title: Optimal criteria and diagnostic ability of serum pepsinogen values for Helicobacter pylori infection
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE20170094
– volume: 26
  start-page: 1039
  year: 2011
  end-page: 1046
  ident: CR10
  article-title: Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2011.06692.x
– volume: 20
  start-page: 25
  issue: Suppl 1
  year: 2004
  end-page: 32
  ident: CR28
  article-title: Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2004.01970.x
– volume: 26
  start-page: 3673
  year: 2020
  end-page: 3685
  ident: CR18
  article-title: Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v26.i25.3673
– volume: 69
  start-page: 2093
  year: 2020
  end-page: 2112
  ident: CR1
  article-title: Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). Screening and eradication of Helicobacter pylori for gastric cancer prevention the Taipei global consensus
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-322368
– volume: 15
  start-page: 293
  year: 2014
  end-page: 298
  ident: CR29
  article-title: Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm
  publication-title: J Dig Dis
  doi: 10.1111/1751-2980.12144
– volume: 70
  start-page: 167
  year: 2004
  end-page: 172
  ident: CR19
  article-title: Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection
  publication-title: Digestion
  doi: 10.1159/000081517
– volume: 100
  start-page: e26562
  year: 2021
  ident: CR23
  article-title: Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000026562
– volume: 21
  start-page: 10
  year: 2021
  end-page: 21
  ident: CR15
  article-title: Helicobacter pylori-negative gastric cancer
  publication-title: Korean J Helicobacter Up Gastrointest Res
  doi: 10.7704/kjhugr.2020.0036
– volume: 38
  start-page: 332
  year: 2003
  end-page: 338
  ident: CR9
  article-title: Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels
  publication-title: J Gastroenterol
  doi: 10.1007/s005350300060
– volume: 14
  start-page: 439
  year: 2020
  end-page: 449
  ident: CR7
  article-title: Role of serum pepsinogen II and Helicobacter pylori status in the detection of diffuse-type early gastric cancer in young individuals in South Korea
  publication-title: Gut Liver
  doi: 10.5009/gnl19091
– volume: 3
  start-page: CD012080
  year: 2018
  ident: CR4
  article-title: Non-invasive diagnostic tests for Helicobacter pylori infection
  publication-title: Cochrane Database Syst Rev
– volume: 30
  start-page: 1473
  year: 2015
  end-page: 1477
  ident: CR21
  article-title: Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.12987
– volume: 9
  start-page: 440
  year: 2011
  end-page: 442
  ident: CR27
  article-title: Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2010.12.009
– volume: 6
  start-page: 174
  year: 2008
  end-page: 179
  ident: CR17
  article-title: Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2007.11.016
– volume: 22
  start-page: e12385
  year: 2017
  ident: CR24
  article-title: The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia
  publication-title: Helicobacter
  doi: 10.1111/hel.12385
– volume: 23
  start-page: e12480
  year: 2018
  ident: CR2
  article-title: The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach
  publication-title: Helicobacter
  doi: 10.1111/hel.12480
– volume: 64
  start-page: 513
  year: 2015
  end-page: 518
  ident: CR12
  article-title: Validation of western Helicobacter pylori IgG antibody assays in Korean adults
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.000050
– volume: 25
  start-page: e12683
  year: 2020
  ident: CR14
  article-title: Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication
  publication-title: Helicobacter
  doi: 10.1111/hel.12683
– volume: 40
  start-page: 938
  year: 2005
  end-page: 944
  ident: CR25
  article-title: Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-005-1677-x
– volume: 27
  start-page: 598
  year: 2012
  end-page: 602
  ident: CR8
  article-title: Serum screening for detection of high-risk group for early-stage diffuse type gastric cancer in Japanese
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2011.06893.x
– volume: 38
  start-page: 55
  year: 2019
  end-page: 66
  ident: CR3
  article-title: Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-018-3414-4
– volume: 2018
  start-page: 8796165
  year: 2018
  ident: CR5
  article-title: Predicting the development of gastric neoplasms in a healthcare cohort by combining Helicobacter pylori antibodies and serum pepsinogen: a 5-year longitudinal study
  publication-title: Gastroenterol Res Pract
  doi: 10.1155/2018/8796165
– volume: 54
  start-page: 1306
  year: 2019
  end-page: 1314
  ident: CR16
  article-title: Analysis of factors associated with recovery of the serum pepsinogen ratio after Helicobacter pylori eradication: a long-term follow-up study in Korea
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2019.1686058
– volume: 6
  start-page: 174
  year: 2008
  ident: 7471_CR17
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2007.11.016
– volume: 15
  start-page: 293
  year: 2014
  ident: 7471_CR29
  publication-title: J Dig Dis
  doi: 10.1111/1751-2980.12144
– volume: 25
  start-page: e12683
  year: 2020
  ident: 7471_CR14
  publication-title: Helicobacter
  doi: 10.1111/hel.12683
– volume: 13
  start-page: 522
  year: 2019
  ident: 7471_CR11
  publication-title: Gut Liver
  doi: 10.5009/gnl18399
– volume: 3
  start-page: CD012080
  year: 2018
  ident: 7471_CR4
  publication-title: Cochrane Database Syst Rev
– volume: 38
  start-page: 332
  year: 2003
  ident: 7471_CR9
  publication-title: J Gastroenterol
  doi: 10.1007/s005350300060
– volume: 22
  start-page: e12385
  year: 2017
  ident: 7471_CR24
  publication-title: Helicobacter
  doi: 10.1111/hel.12385
– volume: 70
  start-page: 167
  year: 2004
  ident: 7471_CR19
  publication-title: Digestion
  doi: 10.1159/000081517
– volume: 30
  start-page: 1473
  year: 2015
  ident: 7471_CR21
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.12987
– volume: 19
  start-page: 88
  year: 2019
  ident: 7471_CR13
  publication-title: Korean J Helicobacter Up Gastrointest Res
  doi: 10.7704/kjhugr.2019.19.2.88
– volume: 100
  start-page: e26562
  year: 2021
  ident: 7471_CR23
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000026562
– volume: 20
  start-page: 25
  issue: Suppl 1
  year: 2004
  ident: 7471_CR28
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2004.01970.x
– volume: 23
  start-page: e12480
  year: 2018
  ident: 7471_CR2
  publication-title: Helicobacter
  doi: 10.1111/hel.12480
– volume: 64
  start-page: 513
  year: 2015
  ident: 7471_CR12
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.000050
– volume: 26
  start-page: 1039
  year: 2011
  ident: 7471_CR10
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2011.06692.x
– volume: 21
  start-page: 10
  year: 2021
  ident: 7471_CR15
  publication-title: Korean J Helicobacter Up Gastrointest Res
  doi: 10.7704/kjhugr.2020.0036
– volume: 50
  start-page: 13
  year: 2002
  ident: 7471_CR22
  publication-title: Gut
  doi: 10.1136/gut.50.1.13
– volume: 27
  start-page: 598
  year: 2012
  ident: 7471_CR8
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2011.06893.x
– volume: 96
  start-page: e7603
  year: 2017
  ident: 7471_CR6
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000007603
– volume: 54
  start-page: 1306
  year: 2019
  ident: 7471_CR16
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2019.1686058
– volume: 26
  start-page: 3673
  year: 2020
  ident: 7471_CR18
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v26.i25.3673
– volume: 2018
  start-page: 8796165
  year: 2018
  ident: 7471_CR5
  publication-title: Gastroenterol Res Pract
  doi: 10.1155/2018/8796165
– volume: 9
  start-page: 440
  year: 2011
  ident: 7471_CR27
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2010.12.009
– volume: 40
  start-page: 938
  year: 2005
  ident: 7471_CR25
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-005-1677-x
– volume: 38
  start-page: 55
  year: 2019
  ident: 7471_CR3
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-018-3414-4
– volume: 2014
  start-page: 481607
  year: 2014
  ident: 7471_CR26
  publication-title: Biomed Res Int
  doi: 10.1155/2014/481607
– volume: 14
  start-page: 439
  year: 2020
  ident: 7471_CR7
  publication-title: Gut Liver
  doi: 10.5009/gnl19091
– volume: 29
  start-page: 147
  year: 2019
  ident: 7471_CR20
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE20170094
– volume: 69
  start-page: 2093
  year: 2020
  ident: 7471_CR1
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-322368
SSID ssj0009716
Score 2.3970015
Snippet Background /Aims The serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels...
Background /AimsThe serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels...
The serum pepsinogen (PG) assay is used to screen subjects at high risk for gastric cancer. Currently, there are few studies on the PG levels for the detection...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 5602
SubjectTerms Antibiotics
Asymptomatic
Biochemistry
Breath tests
Cross-sectional studies
Gastric cancer
Gastroenterology
Hepatology
Infections
Medical screening
Medicine
Medicine & Public Health
Oncology
Original Article
Ratios
Transplant Surgery
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-NTkK8ID5FYaBD4g0smtRxEqQJtWXVQKxMsEp7ixLbGZW2JJD2YX_T_knuXGfRJrGnPMROnNz57ne-L4B3QW4CqQspbFRoIZNQc7KyEVJbslbiPE41ZyMfLdThUn47jU53YNHlwnBYZScTnaA2teYz8o-kZiMncMPPzR_BXaPYu9q10Mh9awWz70qM3YPdkCtjDWB3erA4_tmX4Y1dM1TCOWNBpo_yaTQ-mU6RKcXR7VxUPhDhTVXV489bLlOnieaP4KGHkDjZ0vwx7NjqCdw_8k7yp3C1bG25OUcSA5sLPLZNu6pq4hP8zgFCLRJMxS-WnQf0ePxRndV8Jf1DTFG44s3YsBm_wq8-UqvCVYWT9vKiWdeuxCuSvOEDnPYTTnDGqxe_tiNpYRyaeIlTUo8GaWowngkOfccp49PfeEJfh_OVy6Zpn8FyfnAyOxS-J4PQZJytRUrmY07_SKVKl5o0nTRWj_JkZGg3S5WYUWpTTTBiXGqCRqaIolxbIrk0hS0JTT6HQVVX9gVgUJY0V0XWSCXTQtKQeBTbspS5IVxohxB0vz_TvmA59804z_pSy0yyjJaTOZJl4RDeX89ptuU67hy911E181u3zXpGG8Lb69u06diTkle23tAYJWMVRYlKhvCh44b-Ef9_48u73_gKHoTMgC5cZg8G678b-5pAz7p44zn5H-5p_sk
  priority: 102
  providerName: ProQuest
Title Useful Serum Pepsinogen Levels for Detecting Ongoing Helicobacter pylori Infection in Asymptomatic Subjects: A Cross-Sectional Study Based on 13C-urea Breath Test Findings
URI https://link.springer.com/article/10.1007/s10620-022-07471-2
https://www.proquest.com/docview/2735413032
https://www.proquest.com/docview/2647655868
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1573-2568
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009716
  issn: 0163-2116
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1573-2568
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009716
  issn: 0163-2116
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1573-2568
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009716
  issn: 0163-2116
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELZgV0JcEE9RWKpB4gaWmtZxEm5NaVkeW1awlcopSmwHKu0mFWkP-5v4k3zjJltAgMTJB48dJzP2fJN5WIhnQW4DZQolXVgYqeKh4WRlK5VxsFaiPEoMZyOfzPXxQr1dhss2Kazpot07l6Q_qX9KdtMwdTj6nIu-BxIH72HI5bwgxYvheF9qN_IXngLLjCTMG92myvx5jl_V0R5j_uYW9dpmdlvcamEijXd8vSOuuequuHHSOsLvie-LxpXbc8JW317QqVvD5K8hC_Seg4AaAhSlV44dBJiePlRfam6hY8D4whdopjWb6it600ZjVbSqaNxcXqw3tS_jSjhT-CdN85LGNOHVy087SiyMww8vKYUKtIShwWgiObydUsagX-kMb0ezlc-Yae6LxWx6NjmW7b0L0sAA28gEJmKOb6QTbUoDbaasM4M8HljsWKVjO0hcYgAVRqUB_LFFGObGga3KFq4EYnwgDqq6cg8FBWWJsTp0VmmVFAok0SByZalyC-zneiLoPn9m2qLkfDfGebYvp8wsy7CczLMsG_bE86sx611Jjn9SH3Vczdrt2WTAbKHX3uh-etWNjcXekrxy9RY0WkU6DGMd98SLThr2U_z9iY_-j_yxuDlkgfQhMkfiYPNt654A6GyKvrgeLaO-OBzP0nTO7evP76Zo0-n89GPfS_0P_qz6wA
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemTQJeEH9F2YBDgiewaFLHSZAm1HarWtaWCVppbyGxHVZpSwJphfqZ-A58Nu5cZxVI7G1PeYid2LnL_e58_xh75aXaEyoT3ASZ4iLyFSUray6UQWslTMNYUTbyZCqHc_HxLDjbYb-bXBgKq2xkohXUulR0Rv4OYTawAtf_UH3n1DWKvKtNC43UtVbQh7bEmEvsODHrn2jC1YejI6T3a98fHM_6Q-66DHCF5saSx2gQpYhkMpYqVyi7hTaqnUZtjfwpZKTbsYkVAmMnVwj2OguCVBnchNCZyWMqfIAQsCc6Ikbjb693PD39vC37G9rmq6hXdTiaWtKl7bjkPYmmG0XTUxF7j_t_Q-NW3_3HRWuRb3CP3XUqK3Q3PHaf7ZjiAbs1cU75h-zXvDb56gJQ7Kwu4dRU9aIokS9hTAFJNaBaDEeGnBX4ePhUfCvpiniHTJjZYtFQ0bHBAkYuMqyARQHden1ZLUtbUhZQvtGBUf0eutCn1fMvm5G4MAqFXEMP4VgDTvU6fU6h9tAjffgcZrg7GCxs9k79iM1vhDqP2W5RFuYJAy_Pca4MjBZSxJnAIWE7NHkuUo16qGkxr_n8iXIF0qlPx0WyLe1MJEtwOYklWeK32JurOdWmPMi1ow8aqiZOVNTJlrFb7OXVbfzJyXOTFqZc4RgpQhkEkYxa7G3DDdtH_P-NT69_4wt2ezibjJPxaHqyz-74xIw2VOeA7S5_rMwzVLiW2XPH1cC-3vSP9Act3ju0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIU28oPElygYcEjyBtSZxnARpQl1LtbIPJrFKfQuJ7bBKWxJIq6l_E_8Bfx13rrMIJPa2pzzETpzc-T58v7tj7I2XaU-oXHAT5oqL2FeUrKy5UAa9lSiLEkXZyCen8nAqPs_C2Qb73ebCEKyylYlWUOtK0Rn5HqrZ0Apcf69wsIiz0fhj_YNTBymKtLbtNNYscmRW1-i-NfuTEdL6re-PP50PD7nrMMAVuhoLnqAzlKEWk4lUhUK5LbRR_Szua-RNIWPdT0yiUCkGhUJFr_MwzJTBDxA6N0VCRQ9Q_N-LgiAhOGE0i7qCv5Ftu4oWVcDRyZIuYcel7Ul02ghHT-XrPe7_rRQ7S_ef4KzVeeNt9sAZqzBYc9dDtmHKR2zrxIXjH7Nf08bgbwIUOMsrODN1My8r5Eg4JihSA2gQw8hQmAIfD1_K7xVdUdMh--W2TDTUdGAwh4nDhJUwL2HQrK7qRWWLyQJKNjoqaj7AAIa0ev51PRIXRiDIFRygItaAU71gyAlkDwdkCV_AOX4djOc2b6d5wqZ3QpunbLOsSvOMgVcUOFeGRgspklzgkKgfmaIQmUYL1PSY1_7-VLnS6NSh4zLtijoTyVJcTmpJlvo99u5mTr0uDHLr6N2WqqkTEk3asXSPvb65jdubYjZZaaoljpEikmEYy7jH3rfc0D3i_298fvsbX7Et3D7p8eT0aIfd94kXLUZnl20ufi7NC7S0FvlLy9LAvt31HvoDf7w5Tg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Useful+Serum+Pepsinogen+Levels+for+Detecting+Ongoing+Helicobacter+pylori+Infection+in+Asymptomatic+Subjects%3A+A+Cross-Sectional+Study+Based+on+13C-urea+Breath+Test+Findings&rft.jtitle=Digestive+diseases+and+sciences&rft.au=Jeong%2C+Jong+Hyeon&rft.au=Lee%2C+Sun-Young&rft.au=Kim%2C+Jeong+Hwan&rft.au=Sung%2C+In-Kyung&rft.date=2022-12-01&rft.issn=1573-2568&rft.eissn=1573-2568&rft.volume=67&rft.issue=12&rft.spage=5602&rft_id=info:doi/10.1007%2Fs10620-022-07471-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-2116&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-2116&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-2116&client=summon